ACTIVE

GlaxoSmithKline Biologicals

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result2,4 Md €+9,3 %over 1 year

Revenue7,4 Md €-5,4 %over 1 year

Equity10 Md €-24,9 %over 1 year

Workforce8 371,0 ETP-3,6 %over 1 year

Identity

Source · BCE/KBO

GlaxoSmithKline Biologicals is a Public limited company incorporated in 1990. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Rixensart. It employs on average 8 371,0 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0440.872.918
Incorporation: 01/07/1990
Legal form: Public limited company
Registered office: Rue de l'Institut 89
1330 Rixensart · WallonieSee on map
Contributed capital: 8 379 632 620,82 €
Latest accounts: 31/12/2025
Average workforce: 8 371,0 ETP

Activities (NACE)

21201Manufacture of pharmaceutical preparations· main 21201Manufacture of pharmaceutical preparations 24421Aluminium production

Joint committees (3)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHigh revenue

Financials

Source · NBB, 22 filings

Trend over 15 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	7,4 Md €	-5.4%	7,9 Md €	-11.2%	8,9 Md €	+23.7%	7,2 Md €	+45.6%	4,9 Md €
EBITDA	4,5 Md €	+15.8%	3,9 Md €	-21.7%	4,9 Md €	+34.5%	3,7 Md €	+79.4%	2 Md €
Operating result	2,6 Md €	+16.4%	2,3 Md €	-29.7%	3,2 Md €	+66.5%	1,9 Md €	+346%	431,9 M €
Net result	2,4 Md €	+9.3%	2,2 Md €	-30.9%	3,2 Md €	+63.3%	1,9 Md €	+326%	455,6 M €
Balance sheet
Equity	10 Md €	-24.9%	13,3 Md €	-24.8%	17,7 Md €	+21.0%	14,6 Md €	+12.5%	13 Md €
Total assets	17,8 Md €	-1.5%	18,1 Md €	-9.5%	20 Md €	+15.2%	17,4 Md €	-15.8%	20,6 Md €
Cash	21,7 k €	-99.9%	15,4 M €	-20.2%	19,2 M €	-11.3%	21,7 M €	-49.9%	43,3 M €
Debts	7,2 Md €	+72.2%	4,2 Md €	+174%	1,5 Md €	-15.4%	1,8 Md €	-72.5%	6,6 Md €
Other
Workforce	8 371,0 ETP	-3.6%	8 681,2 ETP	-0.2%	8 701,2 ETP	+1.8%	8 544,0 ETP	+1.6%	8 409,2 ETP

Valuation

Indicative valuation

As an indication, this company is worth

more than 1.000 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

10 active · 24 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Dominique DESCAMPS	Director02/04/2026 → 24/06/2026
Cristelle NOIRHOMME	Director03/09/2025 → 24/06/2026
Aglaé VAN GOETHEM	Director15/09/2023 → 24/06/2026
Benoît ALSTEENS	Director10/01/2023 → 24/06/2026
Emmanuel AMORY	Managing director22/04/2022 → 03/09/2025
Emmanuel FELIX	Managing director25/06/2025 → 24/06/2026
Irène RAPILLY	Director23/06/2021 → 24/06/2026
Jamila LOUAHED	Managing director25/06/2025 → 31/03/2026Director24/06/2015 → 2024 accountsended
Pascal LEGRAIVE	Director10/01/2023 → 24/06/2026
Regis SIMARD	Director10/01/2023 → 24/06/2026

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Antoon LOOMANS	Director23/06/2021 → 2022 accounts
Gabriel MILLAN	Director23/06/2022 → 2022 accounts
Roger CONNOR	Director23/06/2022 → 01/12/2022

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	10/07/2026	02/07/2025	29/07/2024	06/07/2023	20/07/2022	15/07/2021
General meeting	24/06/2026	25/06/2025	26/06/2024	28/06/2023	22/06/2022	23/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 22 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	24/06/2026	10/07/2026	French	PDF
m90-f	31/12/2025	—	30/06/2026	French	PDF
Full model	31/12/2024	25/06/2025	02/07/2025	French	PDF
Full model	31/12/2023	26/06/2024	29/07/2024	French	PDF
Full model	31/12/2022	28/06/2023	06/07/2023	French	PDF
Full model	31/12/2021	22/06/2022	20/07/2022	French	PDF
Full model	31/12/2020	23/06/2021	15/07/2021	French	PDF
Full model	31/12/2019	24/06/2020	30/07/2020	French	PDF
Full model	31/12/2018	26/06/2019	17/07/2019	French	PDF
Full model	31/12/2017	27/06/2018	02/07/2018	French	PDF
Full model	31/12/2016	28/06/2017	11/07/2017	French	PDF
Full model	31/12/2015	20/07/2016	26/07/2016	French	PDF
Full model	31/12/2014	24/06/2015	08/07/2015	French	PDF
Full model	31/12/2013	25/06/2014	30/06/2014	French	PDF
Full model	31/12/2012	26/06/2013	09/09/2013	French	PDF
Full model	31/12/2011	27/06/2012	13/07/2012	French	PDF
Full model	31/12/2010	22/06/2011	19/07/2011	French	PDF
Full model	31/12/2009	23/06/2010	26/08/2010	French	PDF
Full modelCorrection	31/12/2008	24/06/2009	22/09/2009	French	PDF
Full model	31/12/2008	24/06/2009	16/07/2009	French	PDF
Full model	31/12/2007	25/06/2008	18/07/2008	French	PDF
Full model	31/12/2006	27/06/2007	19/07/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

more than 1.000 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

10 active · 24 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Dominique DESCAMPS	Director02/04/2026 → 24/06/2026
Cristelle NOIRHOMME	Director03/09/2025 → 24/06/2026
Aglaé VAN GOETHEM	Director15/09/2023 → 24/06/2026
Benoît ALSTEENS	Director10/01/2023 → 24/06/2026
Emmanuel AMORY	Managing director22/04/2022 → 03/09/2025
Emmanuel FELIX	Managing director25/06/2025 → 24/06/2026
Irène RAPILLY	Director23/06/2021 → 24/06/2026
Jamila LOUAHED	Managing director25/06/2025 → 31/03/2026Director24/06/2015 → 2024 accountsended
Pascal LEGRAIVE	Director10/01/2023 → 24/06/2026
Regis SIMARD	Director10/01/2023 → 24/06/2026

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Antoon LOOMANS	Director23/06/2021 → 2022 accounts
Gabriel MILLAN	Director23/06/2022 → 2022 accounts
Roger CONNOR	Director23/06/2022 → 01/12/2022

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates28/07/2026
Nomination d'administrateurs et mandat du commissaire
PDF
Other14/07/2026
Délégation de pouvoirs
PDF
Mandates08/06/2026
DEMISSIONS, NOMINATIONS
PDF
Mandates05/11/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates03/09/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates30/07/2025
DEMISSIONS, NOMINATIONS
PDF
Mandates05/08/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates03/07/2024
DEMISSIONS, NOMINATIONS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings15 filings

Mandates

Dominique DESCAMPS

Cristelle NOIRHOMME

Irène RAPILLY

Benoît ALSTEENS

Pascal LEGRAIVE

Emmanuel AMORY

Regis SIMARD

Jamila LOUAHED

Emmanuel FELIX

Aglaé VAN GOETHEM

Roger CONNOR

Gabriel MILLAN

Show the 22 other mandates

1990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS ou SMITHKLINE BEECHAM BIOLOGICALSGlaxoSmithKline Biologicals

Rue de l'Institut 89, 1330 Rixensart

Director

Managing director

Director

Managing directorDirector

Managing director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue de l'Institut 89, 1330 RixensartCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00292317

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
GlaxoSmithKline BiologicalsCurrent		CBE
GlaxoSmithKline Biologicals	accounts 2025	Accounts 2025 · 2026-00248320
GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS ou SMITHKLINE BEECHAM BIOLOGICALS	accounts 2025	Accounts 2025 · 2026-00292317
GLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS ou SMITHKLINE BEECHAM BIOLOGICALS	accounts 2021 → 2024	Accounts 2024 · 2025-00232893
GlaxoSmithKline Biologicals	accounts 2011 → 2020	Accounts 2020 · 2021-36800522

Events

02/04/2026
nominationDominique Descamps · administrateur
02/04/2026
nominationPhilippe Denoel · gestion journalière du site de Rixensart
2025
Annual accounts 20252,4 Md €↑
2025
Name changeGLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS ou SMITHKLINE BEECHAM BIOLOGICALS
2025
Name changeGlaxoSmithKline Biologicals
03/09/2025
nominationChristelle Noirhomme · administrateur
03/09/2025
nominationEmmanuel Felix · administrateur délégué
03/09/2025
nominationJamila Louahed · administrateur délégué
01/07/2025
nominationEmmanuel Amory · gestion journalière
25/06/2025
reconductionIrene Rapilly · administrateur
25/06/2025
reconductionAglaé Van Goethem · administrateur
25/06/2025
reconductionJamila Louahed · administrateur
25/06/2025
reconductionRegis Simard · administrateur
25/06/2025
reconductionEmmanuel Amory · administrateur
25/06/2025
reconductionBenoit Alsteens · administrateur
25/06/2025
reconductionPascal Legraive · administrateur
25/06/2025
nominationEmmanuel Félix · administrateur
2024
Annual accounts 20242,2 Md €↓
01/07/2024
nominationEmmanuel Amory · gestion journalière
26/06/2024
reconductionIrene Rapilly · administrateur
26/06/2024
reconductionJamila Louahed · administrateur
26/06/2024
reconductionAglaé Van Goethem · administrateur
26/06/2024
reconductionRegis Simard · administrateur
26/06/2024
reconductionEmmanuel Amory · administrateur
26/06/2024
reconductionBenoit Alsteens · administrateur
26/06/2024
reconductionPascal Legraive · administrateur
26/06/2024
reconductionGert Vanhees · commissaire
2023
Annual accounts 20233,2 Md €↑
22/11/2023
nominationAglaé Van Goethem · administrateur
28/06/2023
reconductionBenoit Alsteens · administrateur
28/06/2023
reconductionEmmanuel Amory · administrateur
28/06/2023
reconductionPascal Legraive · administrateur
28/06/2023
reconductionAntoon Loomans · administrateur
28/06/2023
reconductionJamila Louahed · administrateur
28/06/2023
reconductionIrène Rapilly · administrateur
28/06/2023
reconductionRegis Simard · administrateur
10/01/2023
nominationRegis Simard · administrateur
10/01/2023
nominationBenoît Alsteens · administrateur
10/01/2023
nominationPascal Legraive · administrateur
10/01/2023
nominationJamila Louahed · administrateur
2022
Annual accounts 20221,9 Md €↑
22/06/2022
reconductionRoger Connor · administrateur
22/06/2022
reconductionEmmanuel Amory · administrateur
22/06/2022
reconductionAntoon Loomans · administrateur
22/06/2022
reconductionGabriel Millan · administrateur
22/06/2022
reconductionIrène Rapilly · administrateur
07/05/2022
nominationEmmanuel Amory · administrateur délégué
22/04/2022
nominationEmmanuel Amory · administrateur
2021
Annual accounts 2021455,6 M €↓
2021
Name changeGLAXOSMITHKLINE BIOLOGICALS, EN ABREGE : GSK BIOLOGICALS ou SMITHKLINE BEECHAM BIOLOGICALS
2020
Annual accounts 20201,8 Md €↓
2019
Annual accounts 20192 Md €↑
2018
Annual accounts 2018515,2 M €↑
2017
Annual accounts 2017-261,8 M €↑
2016
Annual accounts 2016-429,6 M €↓
2015
Annual accounts 201593,6 M €↑
2014
Annual accounts 201415,7 M €↓
2013
Annual accounts 2013182,6 M €↓
2012
Annual accounts 2012249,4 M €↓
2011
Annual accounts 2011577,1 M €
01/07/1990
IncorporationPublic limited company

GlaxoSmithKline Biologicals

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events